$DVA Explodes 21.2% to $135 After Earnings as Bulls Eye $140
$DaVita HealthCare Partners(DVA)$
DaVita HealthCare (DVA) Rockets +21.17%: Post-Earnings Gap Up, Eyes $139 Target
Latest Close Data
Closed at $134.73 (ET), surging +21.17% from yesterday's close of $111.19. The stock is now approximately 24.5% below its 52-week high of $178.47.
Core Market Drivers
-
The explosive move was primarily driven by a strong quarterly earnings beat, which significantly boosted investor confidence.
-
Positive guidance and robust operational metrics from the kidney dialysis leader overshadowed broader market concerns.
Technical Analysis
-
Volume exploded to 4.81M shares (Volume Ratio: 3.91), confirming powerful institutional buying interest.
-
The MACD histogram surged to +4.76, indicating strong bullish momentum acceleration as DIF crossed above DEA.
-
The 6-day RSI spiked to 92.36, signaling extreme overbought conditions in the short term, suggesting a potential near-term pullback or consolidation.
Key Price Levels
-
Primary Support: $125.00 (Today's low & psychological level).
-
Strong Resistance: $139.86 (Today's high & near 7-analyst average target of $139.02).
-
Immediate Pivot: $134.73 (Today's close). Holding above this level is key for continued upward momentum.
Valuation Perspective
Forward P/E stands at 8.49, significantly below its historical average of 13.55 and the -1 Std. Dev. of 11.62, indicating the stock remains deeply undervalued despite today's surge. TTM P/S of 0.71 also suggests value.
Analyst Targets
7 analysts have an average price target of $139.02 (range: $126 - $158). Sentiment is cautious but improving, with 1 Buy, 8 Hold, and 1 Underperform ratings.
Weekly Outlook
Expect consolidation between $125 and $140 after the massive single-day gain. A sustained break above $140 could target the $150-$158 zone. A breakdown below $125 would signal profit-taking and test the $111 support.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
